Evidence-Based Clinical Recommendations for the Appropriate Use of Diagnostic Tests in Pediatric Allergology: Focus

Valentina Fainardi1, Matteo Riccò2, Rachele Antignani3

  • 1Paediatric Clinic, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.

Insights

Appropriate diagnostic testing in pediatric allergy improves accuracy and outcomes. Expert recommendations guide the use of specialist consultations and tests for asthma, allergic rhinoconjunctivitis, and vernal keratoconjunctivitis.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Diagnostics
  • Evidence-Based Medicine

Background:

  • Appropriate diagnostic test prescription is vital for quality pediatric allergy care.
  • It impacts diagnostic accuracy, treatment, resource use, and patient outcomes.
  • Expert panel developed recommendations for children with asthma, allergic rhinoconjunctivitis, and vernal keratoconjunctivitis (VKC).

Purpose of the Study:

  • To establish evidence-based clinical recommendations for specialist consultations and diagnostic tests in pediatric allergic conditions.
  • To optimize the use of diagnostic resources in pediatric allergology.
  • To improve diagnostic accuracy and patient management.

Main Methods:

  • Formulated PICO-based clinical questions and prioritized via expert consensus.
  • Conducted systematic literature reviews across major databases.
  • Assessed evidence certainty using the GRADE methodology.

Main Results:

  • Specialist evaluation enhances diagnostic precision and treatment optimization.
  • For asthma, spirometry, FeNO, and allergy testing improve accuracy and control.
  • For allergic rhinoconjunctivitis and VKC, specialist involvement aids diagnosis, immunotherapy selection, management, and complication prevention.

Conclusions:

  • Consistent clinical benefits support consensus recommendations despite moderate to low evidence certainty.
  • Implementing these guidelines can enhance care quality and reduce unnecessary healthcare utilization.
  • Recommendations aim to promote equitable access to diagnostic resources in pediatric allergy.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.